Occudo Quantitative Strategies’s Veoneer, Inc. VNE Stock Holding History

Occudo Quantitative Strategies’s Portfolio VNE Stock Details VNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-63,426	Closed	-$2.34M	–	1477
2022 Q1	$2.34M	Buy	63,426 +54,974	+650%	+$1.96M	0.2%	127
2021 Q4	$300K	Sell	8,452 -3,505	-29%	-$124K	0.03%	766
2021 Q3	$407K	Sell	11,957 -38,343	-76%	-$1.22M	0.05%	616
2021 Q2	$1.16M	Buy	50,300 +22,509	+81%	+$535K	0.18%	177
2021 Q1	$680K	Buy	27,791 +3,268	+13%	+$85.3K	0.15%	234
2020 Q4	$522K	Buy	+24,523	New	+$464K	0.16%	228

Other funds holding VNE

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Occudo Quantitative Strategies's VNE Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Veoneer, Inc. (VNE) in Q2 2022, closing a stake of 63,426 shares — an estimated $2.34M sold.

Occudo Quantitative Strategies first reported a position in VNE in Q4 2020 and held it in 6 quarters. The position peaked at $2.34M in Q1 2022. 1 fund tracked by Wall St. Rank holds VNE as of Q2 2022.

Occudo Quantitative Strategies reported no remaining Veoneer, Inc. position as of Q2 2022 after selling out during the quarter.
Occudo Quantitative Strategies sold 63,426 Veoneer, Inc. shares in Q2 2022, an estimated $2.34M.
Occudo Quantitative Strategies first reported a position in Veoneer, Inc. in Q4 2020 and held it in 6 quarters.
Occudo Quantitative Strategies's Veoneer, Inc. position peaked at $2.34M in Q1 2022.
1 fund tracked by Wall St. Rank held Veoneer, Inc. as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.